Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 11/20 | 0.38 |
| ▸ | RAB9A | P51151 | 11/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20952340 | 0.87 | KMT2A (0.43) | NPC1RAB9ASMN1; SMN2DYRK1AHTT | |
| SCHEMBL19782745 | 0.85 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2DYRK1AHTT | |
| SCHEMBL19783357 | 0.81 | CASP3 (0.35) | NPC1RAB9ASMN1; SMN2DYRK1AHTT | |
| SCHEMBL19782620 | 0.74 | F2RL3 (0.45) | NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL19782939 | 0.74 | F2RL3 (0.43) | NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL21395403 | 0.73 | NPC1 (0.35) | NPC1RAB9ASMN1; SMN2DYRK1AHTT | |
| SCHEMBL19783358 | 0.73 | F2RL3 (0.44) | CYP1A2CYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL19782618 | 0.73 | F2RL3 (0.44) | NPC1RAB9ASMN1; SMN2HTTCYP1A2 | |
| SCHEMBL30189743 | 0.73 | F2RL3 (0.44) | CYP1A2CYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL21395529 | 0.73 | ERN1 (0.39) | NPC1RAB9ASMN1; SMN2DYRK1AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163465-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2021-06-03 | — | — | US | disclosed |
| US-20190292176-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | BISTOL MYERS SQUIBB COMPANY (US) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292176-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | F2, F2RL3, PF4 | NPC1 2639/4885RAB9A 667/4885SMN1; SMN2 3677/4885 |
| US-20210163465-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | F2, F2RL3, F12 | NPC1 2194/4885RAB9A 748/4885SMN1; SMN2 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.